If you are:
FDB Contraindicated or Not Recommended: FETAL DEATH/MORBIDITY W/USE IN 2ND & 3RD TRIMESTER, STOP WHEN PREGNANCY DETECTED
Possibly Safe: NOT RECOMMENDED IN PRE-ECLAMPSIA AND OTHER PREGNANCY-INDUCED HYPERTENSION.
Precaution: LIMITED DATA SUGGEST AMT EXCRETED MINIMAL, NO ADVERSE EFFECTS IN INFANT
Precaution: LIMITED AMOUNTS EXCRETED WITH NO KNOWN ADVERSE EFFECTS IN INFANT.
An adult over 60:
management or monitoring precaution: Cardiovascular-Increased sensitivity to effects on blood pressure. Metabolic-more likely to develop hypokalemia or hypomagnesemia. Endocrine-May worsen glucose control in diabetics. Renal-Not effective with CrCL < 30mL/min.
management or monitoring precaution: Cardiovascular-Monitor for hypotension more closely in the elderly. Metabolic-Monitor for hyperkalemia which has a higher incidence in the elderly. Renal-Increased risk for neutropenia in patients with renal impairment.
Giving Capozide tablet to a child under 12:
management or monitoring precaution: Monitor for excessive and prolonged decrease in blood pressure, urine output, especially neonates. Reports of prolonged hypotension, oliguria and seizures. No established safety and efficacy.